Buy Checkpoint Therapeutics Stock | CKPT Stock Price & Latest News | Public
CKPT

Checkpoint Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About CKPT

    Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302....Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.03
    -0.06
    -0.09
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.09

    Actual EPS
    Q4 2020

    Stats

    Market Cap$160,88M
    Volume6,41k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.50
    1 Year Low$1.05
    Open$2.44
    High$2.46
    Low$2.36

    Buy any stock with any amount of money.

    Download the App
    Download the app